NASDAQ: SGHT Sight Sciences, Inc. 8-K

Sight Sciences wins $34M patent verdict against Alcon, but collection hinges on appeals

Filed March 30, 2026 · Period ending March 27, 2026 · ~1 min read

Key Changes

  • high

    Court upheld jury verdict that Alcon willfully infringed three Sight Sciences patents, awarding $34M in damages plus 10% ongoing royalty on Hydrus revenue through November 2028.

    Item 8.01 view on EDGAR →
  • high

    No cash will be collected until Alcon exhausts appeals or appeal deadline passes, meaning actual payment could be delayed significantly.

    Item 8.01 view on EDGAR →
  • high

    Alcon is challenging patent validity through USPTO reexamination. If patents are invalidated before litigation becomes final, Sight Sciences may be unable to collect the judgment.

    Item 8.01 view on EDGAR →

1 more material change plus the full narrative summary — create a free account to see the rest. Takes 30 seconds.

Partner

Trade SGHT commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 8, 2026 6:35 PM